(Q45397231)

14 December 2017

title

Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection (English)

1 reference

intrahepatic cholangiocarcinoma

14 December 2017

0 references

1 reference

Jin Hyoung Kim

1

1 reference

14 December 2017

Hyung Jin Won

2

1 reference

14 December 2017

Yong Moon Shin

3

1 reference

14 December 2017

Pyo Nyun Kim

4

1 reference

14 December 2017

Sung-Gyu Lee

5

1 reference

14 December 2017

Shin Hwang

6

1 reference

14 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20950977

3 August 2024

publication date

14 October 2010

1 reference

full work available at URL

14 December 2017

https://api.elsevier.com/content/article/PII:S0720048X10004766?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

https://api.elsevier.com/content/article/PII:S0720048X10004766?httpAccept=text/plain

3 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

European Journal of Radiology

3 August 2024

published in

1 reference

14 December 2017

volume

80

1 reference

14 December 2017

issue

3

1 reference

14 December 2017

page(s)

e221-5

1 reference

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

14 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes

3 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

3 August 2024

Cholangiocarcinoma.

3

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre.

3 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma

3 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma

3 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma.

3 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Survival analysis of intrahepatic cholangiocarcinoma after resection.

3 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Cholangiocarcinoma: modern advances in understanding a deadly old disease

3 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors

3 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy

3 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence

3 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Hepatic vein pseudoaneurysm after radiofrequency ablation of recurrent intrahepatic cholangiocarcinoma managed with stent-graft placement

3 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria

3 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection

3 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

3 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival

3 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years

3 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome

3 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Repeated hepatectomy for recurrent intrahepatic cholangiocarcinoma: report of two cases.

3 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver.

3 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough

3 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

3 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma

3 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJRAD.2010.09.019

3 August 2024

Identifiers

1 reference

14 December 2017

1 reference